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Abstract
Disabling hearing loss is the most common sensorineural disability worldwide. It
affects around 466 million people and its incidence is expected to rise to around
900 million people by 2050, according to World Health Organization estimates.
Most cases of hearing impairment are due to the degeneration of hair cells (HCs)
in the cochlea, mechano-receptors that transduce incoming sound information
into electrical signals that are sent to the brain. Damage to these cells is mainly
caused by exposure to aminoglycoside antibiotics and to some anti-cancer drugs
such as cisplatin, loud sounds, age, infections and genetic mutations. Hearing
deficits may also result from damage to the spiral ganglion neurons that
innervate cochlear HCs. Differently from what is observed in avian and non-
mammalian species, there is no regeneration of missing sensory cell types in the
adult mammalian cochlea, what makes hearing loss an irreversible process. This
review summarizes the research that has been conducted with the aim of
developing cell-based strategies that lead to sensory cell replacement in the adult
cochlea and, ultimately, to hearing restoration. Two main lines of research are
discussed, one directed toward the transplantation of exogenous replacement
cells into the damaged tissue, and another that aims at reactivating the
regenerative potential of putative progenitor cells in the adult inner ear. Results
from some of the studies that have been conducted are presented and the
advantages and drawbacks of the various approaches discussed.
Key words: Hearing loss; Cochlear hair cells; Spiral ganglion neurons; Cell regeneration;
Adult stem cells; Cell transplantation
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: This review summarizes the various approaches that are being explored to
establish cell-based therapies that tackle the irreversible loss of sensory cells in the adult
cochlea. Advantages and disadvantages of the various approaches are discussed, based
on published results, and some considerations are made on future perspectives, taking
into account the new developments in the field.
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Hearing loss is the most frequent sensorineural impairment in man; it affects over 6%
of the world's population and its incidence is expected to rise to around 900 million
people  (10%  of  the  population)  by  2050  [World  Health  Organization  (WHO)
estimates, https://www.who.int/pbd/deafness/estimates/en/]; thus this disability
poses  very  serious  social  and  economic  implications.  Most  cases  of  hearing
impairment  are  due  to  degeneration  of  sensory  hair  cells  (HCs),  the  mechano-
receptors  in  the  inner  ear;  damage  to  these  cells  may  be  caused  by  clinically
administered drugs, such as aminoglycoside antibiotics and some chemotherapeutics
(e.g., cisplatin), exposure to high levels of sound, aging, infections, some occupational
hazards, genetic mutations. A smaller percentage of the cases are due to damage to
the spiral ganglion neurons (SGNs) that innervate the HCs in the cochlea and act as
the first relay in the transmission of the incoming sound information to the brain.
Differently from the case in avian and other non-mammalian species, regeneration of
missing cell types does not occur in the mammalian cochlea, and the ensuing hearing
loss is thus permanent. Various approaches to cell regeneration are being explored,
namely gene therapy, administration of survival factors and other biologically active
molecules, and cell-based replacement strategies[1-5]. With regard to the latter studies,
there are two main lines of research, one that is based on the introduction into the
damaged  cochlea  of  exogenous  replacement  cells,  and  another  that  aims  at
reactivating the regenerative potential of putative progenitor cells in the adult inner
ear.
GENERATION OF OTIC CELL TYPES FROM EXOGENOUS
CELL SOURCES
When considering the implantation of exogenous cells into the cochlea, a wide range
of factors must be taken into account that have an important effect on the fate of the
implanted cells and ultimately determine treatment outcome. Considerations such as
the type of exogenous cells, their differentiation status and potential to differentiate
towards other  cell  types,  the  selected route  of  implantation and the host  micro-
environment all play key roles in the survival and integration of the implanted cell
population within the host tissue (Figure 1).
Tissue-specific progenitor cells
There are numerous studies reporting on the potential of different exogenous cell
types to replace sensory cells in the damaged inner ear. Some of the work has focused
on cells  that,  although coming from other  tissues,  may still  share some relevant
characteristics with otic cell types. Wei et al[6] demonstrated the capacity of ciliated
ependymal cells,  obtained from the forebrain germinal zone of adult mice, to get
incorporated into streptomycin-treated cochlear explants, express markers typical of
HCs and establish functional synapses with primary auditory neurons. In addition,
the authors presented data indicating that neural stem cells (NSCs) isolated from the
subventricular  zone  could  be  differentiated  in  vitro  to  neurons  that  established
functional contacts with denervated HCs and with adult SGNs in corresponding co-
cultures. In vivo work carried out by Hu et al[7] demonstrated significant migration of
adult mouse NSCs transplanted into adult guinea pig cochleae to relevant locations
such as the organ of Corti (OC), the spiral ganglion and the auditory nerve tract.
However,  NSC survival  rates  were  very  low;  neomycin-induced damage  to  the
cochlea  and also  Neurogenin2-transduction  of  the  NSCs prior  to  transplantation
improved differentiation of the transplanted NSCs towards a neuronal phenotype and
increased NSC survival. Higher rates of cell survival were registered by Regala et al[8]
following  transplantation  of  murine  adult  NSCs  into  surgically  damaged
vestibulocochlear nerves in adult rats; importantly, the authors observed migration of
murine cells to the brain stem in 50% of the transplanted animals. In another series of
experiments, Edin et al[9]  obtained SGN-like cells from human neural progenitors
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Figure 1
Figure 1  Factors to be considered regarding the use of exogenous cells to replace damaged cochlear cell types. The ultimate fate of implanted exogenous
cells, regarding their survival, differentiation towards desired cell phenotypes, their migration to relevant locations in the cochlea and central auditory targets, and their
physical and functional integration within the host tissue, strongly depends on a variety of factors such as the type of donor cell, its differentiation status and
differentiation potential, the route of implantation and the host micro-environment, among others.
(NPs) by applying culture conditions used to maintain primary cultures of guinea pig
and human SGNs; the cells developed morphological features and expressed an array
of markers typical of SGNs.
Although NSCs from the subventricular zone could be used in autografts, thus
overriding the need for immunosuppression, their isolation poses a series of technical
issues. Therefore, other alternatives have been studied, such as the use of precursor
cells that are resident in the olfactory epithelium[10,11], a readily accessible tissue. These
precursors exhibit stem cell-like properties and express markers typical of otic HCs
(MYOSIN VIIA, CALRETININ, ESPIN, PRESTIN) when co-cultured with cells from
adult cochlea or when exposed to cochlea-conditioned medium[10]. Promising results
were obtained by Xu et al[12], when implanting olfactory epithelium NSCs into the
scala tympani of  a rat  model of  noise-induced hearing loss;  the implanted NSCs
survived and migrated towards host spiral ganglion neurons, although they did not
reach  the  OC.  Yet  the  authors  registered  improved ABR results  in  NSC-treated
deafened animals, compared to those from non-implanted deafened controls.
Notwithstanding, inner ear progenitors have been isolated from embryonic[13,14] and
adult human tissues[15] that would be highly suitable donor cells; however, this is not a
likely option, given their very low numbers. Interestingly, Stefan Heller and his group
have shown that it is possible to isolate cochlear stem cells from post-mortem tissues
without loss of their self-renewing and differentiation potential during the first 10
days following death[16].
Mesenchymal stem cells
Mesenchymal stem cells (MSCs) constitute another candidate donor cell source[17-21].
These are readily accessible cells with potential to differentiate into multiple lineages,
which makes them highly desirable candidates for autologous cell-based therapies;
importantly, they exert immunosuppressive properties[22]  and it has been recently
shown that transtympanic MSC administration into immunocompetent rat hosts does
not elicit an inflammatory response[23]. Kondo et al[17] demonstrated the potential of
murine  MSCs  (mMSCs)  to  acquire  features  of  post-mitotic  neurons  following
exposure to sonic hedgehog and retinoic acid (RA); the cells expressed a whole range
of  glutamatergic  sensory  neuron  markers  (SOX10,  GATA3,  GLUR4,  VGLUT1,
CALRETININ). An additional soluble protein present in hindbrain/somite/otocyst-
conditioned medium and also in embryonic day 18 (E18) OC was required to induce
the expression of additional sensory neuron markers (Brn3a, Neurogenin1, NeuroD).
Further  work  by  this  group[24]  demonstrated  that  Wnt  signalling  induces  the
expression of a whole array of sensory neuron markers through the up-regulation of T
cell leukemia 3 (Tlx3), a transcription factor that promotes differentiation towards
glutamatergic phenotypes. Infusion of Wnt1 was shown to increase the survival and
engraftment  rates  of  mMSCs  implanted  into  the  modiolus  of  ouabain-treated
Mongolian gerbils[24].  Moreover,  the implanted cells  migrated throughout all  the
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cochlear turns and reached the spiral ganglion; some of the cells adopted a clearly
neuronal morphology and expressed neuronal markers.
In another series of experiments, Jeon et al[18] demonstrated that mMSCs could be
differentiated to HC-like cells by exposing the mMSCs to a culture regime used to
differentiate mouse embryonic stem cells (mESCs) into HC-like cells[25] and then over-
expressing Math1, a well-known HC master gene[26]. mMSCs were differentiated to
neurosensory  progenitors  (mMSC-NsPs)  that  expressed  markers  of  early  otic
development, such as Otx2, Nestin, Sox2, Musashi, the early HC genes Math1, Brn3c
and GATA3, and sensory neuronal markers such as TrkB and TrkC, among others.
Transfection  of  mMSC-NsPs  with  Math1  induced  expression  of  the  HC  genes
MyosinVIIa  and  Espin,  and  other  supporting  cell  (SC)  and  neuronal  markers.
Differentiation to a HC phenotype was promoted by co-culturing non-transfected
mMSC-NsPs with E13 chick otocyst cells and also by injecting these cells into chick
otocysts; of note, the injected cells integrated into chick otic epithelia, especially at
sites of damage. Interestingly, when similar studies to those carried out by Kondo et
al[17] and Jeon et al[18] were conducted on human MSCs (hMSCs), some differences were
observed in the response of these human cells to differentiation cues, compared to
that of their murine counterparts[19,20].  Therefore, Durán-Alonso et al[20]  applied to
hMSC cultures protocols that had been employed to direct human foetal auditory
stem cells (hFASCs) from the cochleae of 9-11-week-old foetuses[27] towards HC and
auditory neuron fates[28]. hMSCs were initially differentiated to neural progenitors
(NPs);  further  treatment  of  hMSC-NPs  resulted  in  induced  expression  of
combinations  of  HC  or  SGN  markers,  depending  on  the  culture  regimes  being
applied. HC marker expression (ATOH1, MYOSINVIIa, BRN3C, CALRETININ) was
only  observed  following  treatment  of  hMSC-NPs  that  had  been  generated  in
suspension cultures, pointing to differences in the NP populations that had been
obtained in floating and in adherent cultures. Unlike the results obtained by Jeon et
al[18] on mMSCs, co-culture of hMSC-NPs with chick otocyst cells did not promote
differentiation towards the HC lineage. Expression of sensory neuron markers (SOX2,
GATA3, NGN1, ISLET1, NF200) could only be induced in hMSC-NP cultures that had
undergone RA treatment, thought to render the cultures responsive to subsequent
differentiation cues, such as bFGF. Additional experiments demonstrated that co-
culture of 3D hMSC-NPs with murine cochlear explants promoted the expression of
the neuronal marker NF-200 in these cells. Differently from the protocols applied by
Durán-Alonso et al[20], based on the use of defined media containing specific growth
factor combinations, Boddy et al[19] exposed hMSC cultures to media conditioned by
hFASCs and observed sequential  up-regulation of  otic  progenitor  (PAX8,  PAX2,
SOX2), HC (ATOH1, BRN3C, MYOSINVIIA) and sensory neuron (NGN1, BRN3A)
markers over time. A role was demonstrated for Wnt signalling at the early stages of
otic induction. Additional work by Bas et al[21] demonstrated the capacity of human
nasal MSCs to integrate into gentamicin-treated cochlear explants from post-natal
rats, mostly in the spiral ganglion region; MSCs did not integrate into undamaged
explants.  Higher  numbers  of  cells  expressing  βIII-TUBULIN  were  observed  in
cultures of damaged cochleae that had received hMSCs compared to those that had
not been cultured with the human cells;  over half  of  these neurons were hMSC-
derived, indicating both differentiation of the exogenous cells and a protective effect
on remaining SGNs. hMSC-derived neurons were excitable, and projected neurites
towards the sensory epithelium, further promoted by Wnt signalling activation. In a
different  set  of  experiments,  Schäck et  al[29]  explored the possibility  to  direct  the
differentiation of  hMSCs to  a  glutamatergic  neuron phenotype by conditionally
expressing Ngn1, as already demonstrated by Reyes et al[30] on mESCs. hMSCs were
refractory to adopting the desired fate as, although some glutamatergic neuronal
markers  were  induced  over  time,  their  expression  was  not  maintained  once
conditional expression of Ngn1 was halted[29].
ESCs and induced pluripotent stem cells
In  vivo  survival  and  differentiation  of  transplanted  stem  cell  types:  Not-
withstanding the valuable data obtained on the various types of exogenous cells
mentioned above, the main advancements in the field have come from exploiting the
great proliferative and multilineage differentiation potential offered by ESCs and
induced pluripotent stem cells (iPSCs)[1,5,31].  Experiments have been carried out to
investigate the influence of the host environment on the survival and differentiation
of transplanted stem cells. Survival and induction of neuronal marker expression have
been demonstrated at various timepoints following implantation into various in vivo
animal models[8,32,33]. Additionally, some of these cells were seen to migrate to relevant
locations such as the brain stem[8,32,33]; of note, work by Zhu et al[33] reported teratoma
formation in a number of recipient cochleae following transplantation of murine
iPSCs (miPSCs). Genetic modification of donor stem cells prior to their implantation
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in order to favour their in vivo survival and/or differentiation has also been carried
out[30]. An example of this is the work carried out by Reyes et al[30]; transient Ngn1
expression  in  mECSs  following  their  implantation  into  the  scala  tympani  of
kanamycin-treated  guinea  pigs  resulted  in  increased  migration  and  neuronal
differentiation rates, compared to those of mESC controls[30].
In vitro differentiation. Effect of the otic micro-environment on differentiating cell
types: Another line of work has pursued the in vitro differentiation of ESCs and iPSCs
towards  inner  ear  sensory  cell  types.  A  major  breakthrough  came  from  the
observations by Stefan Heller’s group[25] that sequential incubation of mESC-derived
embryoid bodies in serum-free medium (SFM) containing combinations of EGF, IGF-1
and bFGF resulted in the emergence of inner ear progenitor cells in the cultures; cells
expressed markers that are seen during otic vesicle formation, such as Nestin, Otx2,
Pax2, Bmp7 and Jagged1. In order to promote further maturation of these progenitor
cells,  the cultures  were maintained in defined medium following withdrawal  of
growth factors; early markers Nestin, Pax2 and Bmp7 were downregulated, while the
expression of HC genes such as Math1, Pou4f3, Jagged1, Myosin  VIIa, Parvalbumin,
AchRα9, p31Kip1  was induced; Espin  was also expressed, indicative of stereociliary
morphogenesis. Timing of expression and co-expression patterns of the various genes
supported  the  hypothesis  that  cultures  were  mimicking  in  vivo  inner  ear
developmental stages. Importantly, the authors demonstrated integration of inner ear
progenitors into developing chick otic epithelia. Integration preferentially occurred in
areas of the epithelium that had been damaged during surgery; progenitor cells that
incorporated within HC-bearing regions up-regulated the HC marker MYOSIN VIIA
and some developed F-actin-rich hair bundles that were labelled with an anti-ESPIN
antibody, demonstrating an instructive role of the otic environment. The same group
later developed a more elaborate step-wise approach to differentiate mESCs and
miPSCs[34], where ectodermal induction was promoted at the expense of endoderm
and mesoderm, and the formation of anterior ectoderm was favoured by the addition
of IGF1; FGF combinations were then applied as the main otic inductive signals.
Removal  of  the  growth  factors  present  in  the  medium[25]  resulted  in  Math1  and
MyosinVIIa expression; however , the cells did not present the typical HC morphology
nor  were  hair  bundle  markers  such as  Espin  detected.  These  features  were  only
observed  when  the  otic  progenitor  cells  were  grown  on  a  layer  of  mitotically
inactivated E18 chicken utricle stromal cells;  the cells  in these cultures exhibited
stereociliary bundles and responded to mechanical stimulation in similar ways to
those  of  immature  HCs.  Heller’s  group then extended their  studies  to  hESCs[35],
applying to their cultures a modification of the treatment regime used for mESCs and
miPSCs. The number of cells shown to express a combination of various HC markers
was  low  and  the  cells  resembled  nascent  HCs  that  did  not  further  mature  by
increasing culture times but died instead. Additional studies were carried out[36] on
monolayer cultures of hESCs and hiPSCs, in an attempt to better characterize the
conditions required to obtain bona fide otic cell types from these cultures; this work
identified retinoic acid as a critical factor for bFGF-induced expression of early otic
markers in pre-placodal ectoderm cells. Nevertheless, no further differentiation of the
cells was attained, indicating that the monolayer culture model lacked some of the
factors found in aggregate cultures that promote the differentiation of otic progenitor
cells. Supporting these findings, Abboud et al[37] obtained better results when applying
an otic induction protocol [modified from (34)] to mESC cultures grown in floating
conditions compared to cultures grown as monolayers. A greater proportion of the
cells grown under non-adherent conditions expressed otic progenitor (PAX2, SIX1,
EYA1, SOX2) and early HC markers (MYOSIN VIIA, POU4F3) following treatment,
compared to adherent cultures. Following induction, floating cultures were partially
dissociated and grafted into neomycin-damaged murine cochlear explants; a small
number of these cells survived and integrated into the host tissue, preferentially in
damaged areas of the OC, and expressed MYOSIN VIIA. Interestingly, this was not
observed for any of the progenitors that had integrated outside the lesioned area.
Notwithstanding, attempts have been made to conduct otic induction experiments on
cell monolayers, rather than on three-dimensional cultures that are prone to higher
variability[13,38]. Marcelo Rivolta’s group[13] obtained otic progenitor cells (expressing
PAX8, SOX2, FOXG1, PAX2, NESTIN, SIX1 and GATA3) following 10-12-day-culture
of  hESC  monolayers  in  SFM  containing  a  combination  of  FGF3  and  FGF10  or
combinations of EGF, IGF-1 and bFGF factors[25]. The authors described two different
types of colonies, large epithelioid colonies, composed of flat cells of large cytoplasm
(otic epithelial progenitors, OEPs) and smaller colonies, formed by cells that presented
denser chromatin and cytoplasmic projections (otic neural progenitors, ONPs). HC-
like cells that co-expressed various HC marker combinations were obtained from
OEPs following culture in SFM containing EGF and RA. A similar  protocol  was
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applied by Chen et al[39] to generate OEPs and ONPs from hiPSCs. OEPs were grown
on mitomycin-treated chicken embryonic utricle stromal cells, in SFM containing EGF
and RA, to yield rates of over 40% of cells that co-expressed HC markers (BRN3C,
MYOSIN VIIA and ATOH1) and demonstrated some other characteristics of HCs
such as the presence of mechano-transduction channels and some electrophysiological
activity. In in vitro co-cultures of OEP-derived HC-like cells and SGNs from neonatal
mice,  SGNs  extended  neurites  to  the  induced  HC-like  cells  and  formed  active
synapses. Additionally, OEPs were transplanted into the scala tympani of Slc26a4-null
mice that present HC defects. At 4 wk post-transplantation some cells had migrated to
the scala media and had integrated into the damaged epithelium, expressing MYOSIN
VIIA and forming synaptic connections with native SGNs. The same protocol was
applied by Azel Zine’s group[38] to obtain HC-like cells from hiPSCs; otic induction
was significantly increased when the EGF/RA step was substituted by treatment with
a Notch inhibitor, in agreement with accumulated evidence that Notch plays a key
role in the differentiation of sensory otic lineages. Thus ATOH1 expression was much
higher in cultures exposed to the Notch inhibitor and around 50% of the cells in these
cultures expressed MYOSIN VIIA, as opposed to cultures grown in the presence of
EGF/RA, where the percentage of cells expressing this HC marker did not reach 5%.
Unfortunately, no hair bundle formation was detected on differentiating cells. Very
importantly,  hiPSC-derived otic  progenitors  could survive in an in  vivo  ototoxic
damage model[40]. The cells were implanted into the cochlea of adult guinea pigs that
had  undergone  amikacin  treatment.  Two  weeks  after  implantation,  surviving
progenitors had engrafted within the damaged cochlear sensory epithelium and
expressed MYOSIN VIIA; some expressed SOX2, pointing at their differentiation
towards a SC type. Interestingly, those progenitors that had integrated outside the
area of the OC did not express MYOSIN VIIA. Similar results were obtained when
implanting murine otic progenitors into the same in vivo model.
In addition to the protocols discussed above, other HC induction protocols have
been described. An example is provided by the work by Ouji and colleagues[41,42],
based on the culture of mESC-derived embryoid bodies in medium conditioned by
ST2 stromal cells. This treatment led to the induction of HC marker expression and
the formation of stereocilia-like structures in some of the cells; additionally, some cells
were  shown to  integrate  into  developing chick  otocysts.  A simpler  method was
developed by Ohnishi et al[43]  in an attempt to eliminate the need for conditioned
media, complex growth factor combinations, or the use of xenogeneic cells.  They
reported expression of MYOSIN VIIA and βIII TUBULIN proteins in hiPSC cultures
that  had  been  grown  in  defined  medium,  using  bFGF  as  sole  growth  factor;
stereocilia-like protrusions were observed in some MYOSIN VIIA-expressing cells.
Although simpler than other methods, induction rates were extremely low.
Differently from the methods described above, Domingos Henrique’s group[44]
directly programmed mESCs to become HCs by forcing the simultaneous expression
of Gfi1, Pou4f3 and Atoh1 (GPA), coding for three key transcription factors in HC
development. Theirs was an extremely fast and efficient induction protocol that in 8-
12 days yielded large numbers of cells (54% ± 2%) that co-expressed various HC
markers.  Addition  of  RA  or  inhibition  of  the  Notch  pathway  during  GPA
overexpression resulted in increased HC induction rates (84% ± 1% and 70% ± 2%,
respectively). Some maturation of the MYOSIN VIIA+ cells were observed from d8 to
d12, indicated by a decline in SOX2 expression and clear expression of the hair bundle
proteins ESPIN and CADHERIN23 in membrane protrusions that did not reach the
degree of organization found in normal HC stereociliary bundles. Nevertheless, FM1-
43  incorporation  experiments  pointed  at  the  presence  of  potentially  functional
mechano-transduction channels. Reyes et al[30] also resorted to genetic modification of
mESCs in  order  to  guide their  differentiation in  vitro  and attained high rates  of
differentiation of mESCs to glutamatergic neurons through the transient expression of
Ngn1 in the cultures.
ESCs and iPSCs have also been differentiated in vitro[13,45] and in vivo towards SGNs.
Some of the work has consisted on generating stem cell-derived NPs that have then
been implanted in the inner ear to promote their differentiation towards the SGN
lineage. An example of this approach is the work carried out by Corrales et al[46], who
grafted mESC-NPs into the cochlear nerve trunk of ouabain-treated gerbils. Implanted
cells  survived  and  demonstrated  βIII  TUBULIN  and  PERIPHERIN  expression;
interestingly,  they  extended  processes  towards  the  denervated  HCs  in  the  OC,
indicating a role of the host environment as provider of survival, differentiation and
guidance  cues.  Unfortunately,  no  functional  recovery  could  be  demonstrated.
Coleman et al[47] implanted mESC-NPs into the scala tympani of chemically deafened
guinea pigs, selecting a delivery route that was clinically more relevant than others
previously used, such as direct injection into the auditory nerve. Transplanted cells
were observed in the scala tympani of transplanted hosts at 4 wk post-transplantation.
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mESC-derived cells  were  also  observed in  Rosenthal’s  canal,  close  to  surviving
endogenous SGNs,  although their  numbers  were  extremely low,  indicating that
delivery into the scala tympani was not an efficient route to direct exogenous cells to
the Rosenthal’s canal. Sekiya et al[48] transplanted mESCs that had been exposed to the
neuralizing activity of stromal cell-derived medium into the internal auditory meatal
portion of the auditory nerve, aiming at minimizing the risk of damage to the cochlea
and optimizing delivery to  the target  site.  The group observed migration of  the
implanted cells along the damaged auditory nerve, into the Rosenthal´s canal and to
the scala media. Interestingly, no significant migration was observed when mESC-
NPs were implanted in intact auditory nerves; instead, the cells extended numerous
neuritic processes along the nerve. These observations, together with the fact that
implanted cells exhibited varying morphologies depending on their location, pointed
at an interaction of the exogenous cells with local environmental cues. In another
series of experiments, Okano et al[49] recorded higher rates of exogenous cell survival
when implanting mESC-NPs in the modiolus of deafened guinea pigs, compared to
their implantation in non-injured ears. Surviving cells differentiated to neurons that
extended projections towards peripheral and central auditory targets. Interestingly,
although synapse formation could not be demonstrated, some functional recovery
was observed in some animals.
Work carried out by Albert Edge’s group on hESCs identified BMP4 as a critical
molecule to differentiate hESCs towards SGNs[45]. When implanted in an in vivo gerbil
model, hESC-derived NPs differentiated and engrafted in the auditory nerve trunk.
The neurons extended projections to the sensory cochlear epithelium and towards the
brain  stem.  Unfortunately,  synapse  formation  could  not  be  demonstrated.  As
mentioned above, hESC-NPs were also generated in Rivolta’s laboratory (otic neural
progenitors, ONPs)[13]. ONPs were transplanted into the modiolus of ouabain-treated
gerbils; implanted cells survived and formed an ectopic ganglion in the modiolus,
with neurons that extended neurite projections to the OC. At 10 wk post-implantation
some of the hESC-derived neurons had migrated from the ectopic ganglion to the
Rosenthal’s  canal  and  some  cells  were  seen  migrating  towards  the  brainstem;
SYNAPTOPHYSIN staining pointed to the establishment of synaptic connections of
hESC-derived neurons with neurons in the cochlear nucleus. Importantly, functional
tests carried out at 4 wk post-transplantation demonstrated an improvement in ABR
thresholds of animals that had received ONPs; functional restoration correlated to the
increase  in  neural  density  resulting from ONP transplantation.  ONPs were  also
obtained  from  hiPSCs [39]  and  could  be  differentiated  to  neurons  expressing
combinations of sensory neuron and other neuronal markers (βIII-TUBULIN, BRN3A,
NF200, NEUROD1, ISLET1). These neurons established active synapses in co-cultures
with HC-like cells that were also generated from hiPSC cultures[39].
Survival  of  NPs  derived  from  miPSCs  has  also  been  demonstrated  in  vivo[50],
following transplantation into mouse cochleae; some of the surviving cells expressed
the glutamatergic neuron marker VGLUT1 and were seen to project neurites towards
cochlear HCs[50].  Differently to the approaches described above,  Ishikawa et  al[22]
differentiated hiPSC-NPs to neurons in vitro, prior to their transplantation. Although
the cultures contained a mixture of neuronal types and they were at various stages of
maturation,  around 95% of  the cells  expressed VGLUT1.  The authors conducted
parallel differentiation experiments on Matrigel-coated plates and on 3D collagen
matrices, obtaining similar results. Implantation of 3D cultures into the scala tympani
of normal hearing-competent guinea pigs demonstrated differentiation of hiPSC-NPs
to glutamatergic neurons although there was a significant decline in the number of
surviving exogenous cells during the first two weeks following transplantation. Based
on the loss of Oct3/4 expression in differentiated cultures, the authors defended the
safety  of  their  approach,  since  one  of  the  risks  posed  by  the  transplantation  of
undifferentiated cell types such as ESCs and iPSCs is their potential to give rise to
tumours. Nevertheless, the risk of tumour formation by implanted cells cannot be
completely eliminated, and thus efforts have also been made to obtain otic sensory
cell-like cells from fully differentiated somatic cell  types that may overcome this
problem. In line with this argument,  Durán-Alonso et  al[51]  applied to cultures of
human fibroblasts the direct conversion protocol described by Costa et al[44]. Over-
expression of the GPA combination of transcription factors induced the expression of
HC markers MYOSIN VIIA, BRN3C and ESPIN. Despite good transduction rates and
a strong increase in HC gene transcript expression, clear morphological changes and
expression of a combination of HC proteins (MYOSIN VIIA, ANNEXIN A4, ESPIN)
was only observed when transduced cells were cultured in SFM containing EGF and
RA, as employed by Rivolta’s group on hFASCs[13,28]; however, cell polarization or
formation of stereocilia-like protrusions were not observed. Transcriptomic analyses
of these cultures indicated an enrichment of genes related to HC development and
differentiation, together with genes involved in neuronal differentiation.
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Organoids:  Some recent  work has  resulted in  the establishment  of  3D inner  ear
organoid cultures[52-56], where differentiation of ESCs and iPSCs is conducted under
culture conditions that sequentially recreate the stages leading to the development of
various inner ear cell types in vivo. Thus the cultures are exposed to combinations of
factors that activate and inhibit key signalling pathways to ultimately render the step-
wise formation of non-neural ectoderm, pre-placodal and otic placodal epithelia, and
otic  vesicle  epithelium  that  ultimately  gives  rise  to  HCs,  SCs  and  sensory
neurons[52,54,57]. Differentiating cultures are provided with added extracellular matrix
proteins that support the self-organisation of the cells into biologically more relevant
3D  cultures  than  those  growing  as  monolayers  on  tissue  culture  plates.  This
arrangement yields clusters of HC-like cells that express an array of HC markers and
exhibit basal-to-apical polarization, ESPIN-labelled hair bundles containing functional
mechano-transduction  channels,  and a  diversity  of  voltage-dependent  currents.
Neurons also emerge within these cultures  that  establish synaptic  contacts  with
developing HCs[52,57]. Most of the work that has been carried out to date on inner ear
organoids has focused on dissecting the identities and the complex interactions of the
signalling pathways that  regulate  inner  ear  development[57-59],  but  the numerous
advantages offered by these cultures, in terms of cellular complexity, cell phenotype
maturation  and numbers  of  induced  cells  make  them ideal  substrates  for  other
important applications in the field[60,61]. At present there are important shortcomings to
the use of inner ear organoids as sources for HC transplantation into the cochlea. A
major hurdle is the fact that the applied protocols yield vestibular HC types[56,62]. Work
is underway to elucidate what elements are missing in the current cultures that may
yield cochlear HCs; Jeong et al[55] have recently described a series of modifications to
the original method that result in the generation of various HC types in organoid
cultures,  some  expressing  cochlear  HC  markers.  On  the  other  hand,  inner  ear
organoids may already constitute valid substrates to investigate SGN development
and  initiate  studies  towards  a  possible  application  in  approaches  to  SGN
regeneration. Perny et al[54]  have modified initially published protocols, obtaining
mESC-derived cultures that contain a large number of neurons that express a whole
array  of  sensory  otic  neuron  markers  (GATA3,  PROX1,  ISLET1,  p75,  MAFB,
PERIPHERIN) and display electrophysiological properties similar to those of SGNs.
Very interestingly, characterization of the neurons present in these cultures indicates
that these are not vestibular neurons but cochlear SGNs.
Summarizing what has been discussed above, a number of exogenous cell types
have  been  evaluated  for  their  potential  to  replace  damaged  cells  in  the  adult
mammalian cochlea, in a quest for a promising approach to hearing restoration. Some
of these results are summarized in Figure 2.
GENERATION OF OTIC CELL TYPES FROM ENDOGENOUS
OTIC PROGENITORS
Various  populations  of  stem  cell/progenitor  cells  have  been  described  in  the
mammalian inner ear at embryonic and neonatal stages[14,27,63-65]. Initial studies on inner
ear progenitors were based on the identification of cells in the inner ear that could
self-renew in culture and give rise to different otic cell lineages when induced to
differentiate[64,66,67];  otic progenitors have been identified in the vestibular sensory
epithelium, the OC, the spiral ganglion and the stria vascularis[27,64,66,67]. On the other
hand,  since  no regeneration takes  place  at  later  developmental  stages  following
damage to HCs and/or SGNs, it has been traditionally accepted that there is no stem
cell reservoir in the adult mammalian cochlea. This belief is supported by the fact that
the features that characterize the progenitor cell populations that are present in the
early  stages  of  cochlear  development  are  not  encountered  in  more  mature
tissues[63,64,68]. Sphere-formation tests[63,66] indicate that there is a steep decline in the
numbers of putative cochlear stem cell-like cells during the first three weeks following
birth[63,64,68]; this has been associated to a decrease in the expression of stem and early
otic markers like Nestin, Musashi1, Otx2, Mcm2, Pax2, Islet1[64], and the up-regulation of
genes such as P27 in SCs from the OC of older organisms[63]. Work by Azel Zine’s
group[69] demonstrated widespread expression of the stem/progenitor cell markers
Gfap, ABCG2, SOX2 and JAGGED1 in cochlear SCs of P3 mice, and Nestin expression,
which was mostly localized to inner phalangeal and border cells. Besides changes in
the levels of expression of some of these genes, the authors unveiled a shift in the
expression of Gfap and Abcg2 from the OC to SCs in the limbus area, and of Jagged1 to
limbus interdental and Hensen cells; interestingly, these are areas where adenoviral-
mediated  Math1  overexpression  has  led  to  HC  regeneration  in  adult  cochleae,
resulting in improved hearing function[70,71]. These and other observations add support
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Figure 2
Figure 2  Overview of exogenous donor cell types that have been tested for their potential to give rise to hair cell- and / or spiral ganglion neuron-like cells.
Advantages and disadvantages of the various donor cell types are indicated, as well as the main results that have been obtained with these cells in in vivo and in vitro
studies. HC: Hair cell; SGNs: Spiral ganglion neurons.
to the notion that stem cell-like cells could still persist in the adult cochlea that have
their  regenerative potential  curtailed by incoming signals  from the surrounding
tissue. Isolation from the post-mitotic cochlear epithelium of sphere-forming cells that
can proliferate in vitro points at the presence of inhibitory signals originating from the
cochlear tissue[63,64,66]. Moreover, despite the inability of the adult cochlea to regenerate
damaged cell types, stem cells have been isolated from fully mature cochlear tissues
that self-renew and give rise to differentiated otic lineages in vitro[15,16]. The numbers of
these cells are very low; in addition, there are some technical difficulties associated to
the  study  of  cochlear  tissues  from  adult  mammalian  models.  As  a  result,  the
properties  of  various  SC  populations  considered  to  be  potential  adult  cochlear
progenitor  cells  have been mostly  explored on early  post-natal  animals,  always
bearing in mind that these models do not faithfully reproduce the conditions in the
adult organ.
As already mentioned, a number of progenitor cells have been described in the
embryonic  cochlea[14,65,72,73].  Chen  et  al[27]  isolated  NESTIN+  SOX2+  PAX2+  otic
progenitor cells from the cochleae of 10-week-old human foetuses; as discussed above,
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these cultures could be propagated as adherent cultures and presented two clearly
different  cell  morphologies,  which  could  be  differentiated  towards  HC or  SGN
lineages. Roccio et al[14] later isolated a population of EPCAM+ CD311+ cells from the
cochlea of 8-12-week-old foetuses; these cells proliferated in organoid cultures and
could give rise to HCs. Other progenitor populations have been analysed at neonatal
stages, soon after birth[65,69,73,74]; this is the case of SOX2+ NESTIN+ cells of the great
epithelial ridge, considered to give rise to new inner border cells and inner phalangeal
cells when these are damaged during the first two weeks following birth[73];  these
progenitor  cells  are  no  longer  present  in  the  cochlea  at  the  onset  of  hearing.  A
population  of  NESTIN+  cells  that  do  not  express  HC  or  SC  markers  has  been
identified beneath the basilar membrane of post-natal animals[72,75]. These cells, called
tympanic border cells, proliferate over the first 1-2 wk following birth; then, their
proliferative potential declines, correlating with decreased Wnt signalling. Jan et al[72]
observed migration of tympanic border cells into the OC and adjacent tissues during
the first two weeks after birth; these cells then differentiated into HCs and various SC
types. A small number of these cells are thought to remain in the adult cochlea, in a
quiescent state. A good number of studies have been conducted in recent years to
characterize  a  population  of  SCs  that  express  the  adult  stem  cell  marker  LGR5
(Leucine-rich repeat-containing G-protein coupled Receptor 5)[65,74,76,77]. These have
been identified as HC progenitors in the neonatal cochlea[65,74,78], demonstrating some
proliferative capacity and regenerating HCs in response to HC damage[65,74],  Wnt
signalling activation[65,79,80] and/or Notch signalling inhibition[81,82]. Efforts are being
made to further unveil the signalling cascades that regulate the proliferation and HC
regeneration abilities of LGR5-expressing cells[83-85], since expression of this stem cell
marker persists in a reduced number of Deiter SCs in the adult cochlea[76]. However,
most  data  have  only  been  obtained  on  neonatal  animal  models [80-82 ,84].  The
identification of  a  progenitor  cell  population in  the  cochlea  and elucidating the
reasons why these cells appear unable to regenerate the damaged tissue would be of
the utmost importance; these progenitors would constitute an ideal cell source for
regeneration therapies, placed at the appropriate location, and would override some
of the main hurdles encountered by approaches that rely on the use of donor cells
from exogenous sources (Figure 3).
CONCLUSION
While work is underway to better characterize the complex network of signalling
cascades that regulate inner ear development in vivo, some promising results have
been obtained when transplanting cells from exogenous tissues into the inner ear of
animal  models,  demonstrating  the  formation  of  synaptic  contacts  between  the
implanted cells and HCs in the cochlear epithelium as well as with SGNs and neurons
in areas of the brain stem[13,48,49]. There are many important questions to consider when
contemplating this type of approach. Sufficient numbers of transplanted cells must
survive, differentiate and integrate both physically and functionally into the damaged
inner ear tissue in order to enable some degree of hearing restoration. Regeneration of
HCs in the OC will convey survival of the donor cells in potassium-rich endolymph, a
hostile  medium to  a  large  number  of  cell  types;  work  is  underway  to  establish
protocols that increase the chances of survival of implanted cells in the scala media
without  compromising  the  internal  conditions  that  are  required  for  the  correct
functioning of the organ[86,87]. There is also the question of what cell type should be
selected as donor cell and whether the cells should be transplanted as undifferentiated
stem cells, partly differentiated progenitors, or fully differentiated cells. Stem cells
and progenitor cells have been proposed as better candidates for transplantation than
fully differentiated cells, on the argument that these cells should be more responsive
to endogenous environmental  cues.  There are however concerns regarding their
safety, in terms of a possible risk of tumour formation following implantation, and
also the possibility that these cells may not differentiate to the desired cell type[22]; this
is  one of  the  hurdles  encountered by NSC transplantation,  when differentiation
towards glial cell types often overrides neuronal differentiation. Improved survival
and differentiation rates have been observed when using donor cells  genetically
engineered to express lineage-specific genes[7,30,42] and also when coupling exogenous
cell  transplantation with the administration of instructive factors[24,30].  One of the
reasons to pursue the trans-differentiation of fully differentiated somatic cell types is
the risk of teratoma formation by transplanted cells, as reported by Nishimura et al[88]
following implantation of miPSC-NPs. A first report on the trans-differentiation of
human fibroblasts to cells expressing HC markers constitutes a proof-of-principle
study[51]; future experiments should be conducted that allow the transient expression
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Figure 3
Figure 3  Considerations on the presence of a putative progenitor cell population in the adult mammalian cochlea. There is yet no clear evidence that such
cells are present in the adult cochlea. Some data have been obtained that support their existence; additionally, some reports point to changes in the epigenetic status
of these progenitor cells and/or in the surrounding micro-environment as possible causes of their inability to activate a regenerative programme in the damaged tissue.
of the transgenes using non-integrative vectors. In addition, approaches such as that
described by Itakura et al[89], who have developed iPSC lines that carry an inducible
caspase-9 gene,  will  ensure a safer  application of  these cells;  this  is  all  the more
relevant when considering the vast potential of iPSCs as donor cells in instances
where  hearing loss  is  due to  a  genetic  mutation.  Survival  and differentiation to
appropriate cell lineages will also depend on the specific locations reached by the
transplanted cells, which will in turn be affected by the route of implantation that is
selected. Careful selection of the delivery route when considering donor cell-based
therapies will be of paramount importance; thus, for example, although implantation
into the scala tympani could be a method of choice when considering the convenience
to the patient, this might result in insufficient numbers of exogenous cells reaching the
target  areas[47,48].  It  has  been  conclusively  shown  that,  independently  from  the
transplanted cell type, the survival and engraftment rates of the exogenous cells are
much higher in areas of damage, probably due to the release of relevant factors into
the local microenvironment. There are doubts as to whether the observations made on
experimental  animal models do in fact  mimic the clinical  situation,  and whether
transplanted  cells  would  encounter  a  similar  microenvironment  in  the  patient.
Identification  of  the  factors  that  promote  the  survival  and  differentiation  of
transplanted cells  in  animal  models  will  nevertheless  constitute  highly valuable
information[90].  There are other concerns to the transplantation of exogenous cells,
such as the need for immunosuppression when receiving allogeneic donor cells; work
by various groups have underlined the immunosuppressive properties of MSCs[22].
Very importantly,  a major obstacle to the integration of implanted cells  in the
damaged OC is its cellular complexity and the fact that this is a highly organized
epithelium, refractory to the integration of exogenous cells. This and the fact that
formation of  ectopic  ganglia  by exogenous cell-derived neurons results  in  some
recovery of the hearing function make HC replacement a longer-term goal than SGN
regeneration,  as  supported  by  the  promising  results  that  some  groups  have
reported[13,49,91]. Yet, differentiation studies are proving highly valuable at dissecting
the  signalling  pathways  involved  in  inner  ear  development  and  their  complex
interactions. Huge progress has been made, as demonstrated by the generation of
inner ear organoid models that are shedding very important information on inner ear
development and provide excellent cellular models that may yet be used in future
transplantation approaches.  Moreover,  the availability of  inner ear  organoids of
human origin is of great importance, especially in light of the interspecies variability
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that has been observed[13,20]. Use of gene edited-hiPSC cell lines to generate organoids
provides an extremely useful tool to identify instructive molecules and to study the
effect of gene mutations on inner ear development[57,59,61].
With regard to a re-activation of the regenerative program in the adult cochlea,
although extremely  interesting,  this  is  still  a  largely  unknown area.  It  has  been
demonstrated that cells with stem cell-like properties persist in the adult inner ear;
characterization of the progenitor population in the vestibular system is proving less
difficult, since this tissue maintains some very limited regenerative capacity in adult
mammals[92]. However, the identity of progenitor cells in the adult cochlea has not yet
been confirmed. Data from the Raphael and the Zine labs[69,71] suggest that there may
be a reduced pool of stem cell-like cells in the limbus area of adult cochlea that have
been displaced from their location in the OC during the neonatal period and that may
be responsive to specific signals such as Atoh1 expression. On the other hand, there
are also low numbers of tympanic border cells and LGR5+ cells present in the adult
cochlea; these populations are responsive to Wnt sigalling and can give rise to HCs
and SCs during postnatal stages. However, their role and properties in the adult
cochlea have not been characterized. Very interestingly, new evidence is emerging
that point at changes in the epigenetic landscape of LGR5+ cells in the adult cochlea,
opening the door to new approaches to reactivate a regenerative programme in these
cells[93,94]. It is also important to remember that all the information we have on the
various progenitor cell populations has been obtained on animal models. There are
only two reports on the presence of LGR5+ cells in the human foetal cochlea[14,95].
Intriguingly, Johnson Chacko et al[95] have described LGR5 expression in cochlear HCs
of 12-week-old foetuses, but not in SCs. Although there are doubts concerning the
reliability of  the currently available LGR5 antibodies,  this  observation raises the
question of whether the data that have accumulated on murine cochlear LGR5+ cells
are in agreement with the characteristics of their human counterparts.
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